CS logo
small CS logo
Horizon Research Group, Inc

Mobile, Alabama, United States
Medical clinic in Mobile, Alabama
3662 Dauphin St # D, Mobile, AL 36608

About Horizon Research Group, Inc


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
10
Pacira Pharmaceuticals, Inc
3
AstraZeneca
2
Teva Branded Pharmaceutical Products R&D, Inc.
2
Abbott Nutrition
1
BioDelivery Sciences International
1
Bristol-Myers Squibb
1
Cara Therapeutics, Inc.
1
Cephalon
1
Encore Dermatology, Inc.
1
LEO Pharma
1
Total Rows: 14

Clinical Trials at Horizon Research Group, Inc


During the past decade, Horizon Research Group, Inc conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 15 clinical trials were completed, i.e. on average, 750% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2211Started TrialsCompleted Trails20160123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee
2006-12-01
2007-11-01
Completed
547
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
2008-07-01
2013-03-01
Completed
5,614
An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain
2008-09-15
2009-05-08
Completed
1,050
Tanezumab in Osteoarthritis Of The Hip
2008-11-17
2010-08-13
Completed
627
Extension Study Of Tanezumab In Osteoarthritis
2009-02-06
2011-06-23
Terminated
2,147
Phase 3 Study of Local Administration of SKY0402 for Postoperative Analgesia in Subject Undergoing Breast Augmentation
2008-11-01
2009-02-01
Terminated
136
Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain
2008-12-01
2010-01-01
Completed
213
A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension
2008-12-22
2009-10-13
Completed
155

Rows per page:

1–27 of 27

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Horizon Research Group, Inc" #1 sponsor was "Pfizer" with 10 trials, followed by "Pacira Pharmaceuticals, Inc" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Teva Branded Pharmaceutical Products R&D, Inc." with 2 trials sponsored and "Abbott Nutrition" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Horizon Research Group, Inc" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Great Lakes Drug Development, Inc." with 1 trials as a collaborator, "Integrium" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Prosoft Clinical" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 10Pfizer: 10Pacira Pharmaceuticals, Inc: 3Pacira Pharmaceuticals, Inc: 3AstraZeneca: 2AstraZeneca: 2Teva BrandedPharmaceuticalProducts R&D, Inc.: 2Teva BrandedPharmaceuticalProducts R&D, Inc.: 2Abbott Nutrition: 1Abbott Nutrition: 1BioDelivery SciencesInternational: 1BioDelivery SciencesInternational: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Cara Therapeutics, Inc.: 1Cara Therapeutics, Inc.: 1Cephalon: 1Cephalon: 1Encore Dermatology, Inc.: 1Encore Dermatology, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsBristol-Myers Squibb: 1Bristol-Myers Squibb: 1Great Lakes DrugDevelopment, Inc.: 1Great Lakes DrugDevelopment, Inc.: 1Integrium: 1Integrium: 1Pfizer: 1Pfizer: 1Prosoft Clinical: 1Prosoft Clinical: 1

Clinical Trials Conditions at Horizon Research Group, Inc


According to Clinical.Site data, the most researched conditions in "Horizon Research Group, Inc" are "Osteoarthritis" (5 trials), "Chronic Pain" (4 trials), "Psoriasis" (4 trials), "Low Back Pain" (3 trials) and "Pain" (3 trials). Many other conditions were trialed in "Horizon Research Group, Inc" in a lesser frequency.

Clinical Trials Intervention Types at Horizon Research Group, Inc


Most popular intervention types in "Horizon Research Group, Inc" are "Drug" (22 trials), "Biological" (5 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "CP-690,550" (2 trials), "Hydrocodone ER" (2 trials), "bupivacaine liposome injectable suspension" (2 trials) and "tanezumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Horizon Research Group, Inc


The vast majority of trials in "Horizon Research Group, Inc" are 25 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Horizon Research Group, Inc


Currently, there are NaN active trials in "Horizon Research Group, Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Horizon Research Group, Inc, undefined suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Horizon Research Group, Inc, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 20Phase 3: 20Phase 2: 6Phase 2: 6Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 21Completed: 21Terminated: 6Terminated: 6